Amdocs/$DOX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Amdocs
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
- Ticker
- $DOX
- Sector
- Business services
- Primary listing
- NASDAQ
- Employees
- 26,969
- Headquarters
- Saint Louis, United States
- Website
- www.amdocs.com
Amdocs Metrics
BasicAdvanced
$4.7B
9.57
$4.68
0.41
$2.23
5.08%
Price and volume
Market cap
$4.7B
Beta
0.41
52-week high
$84.95
52-week low
$39.96
Average daily volume
1.8M
Dividend rate
$2.23
Financial strength
Current ratio
0.94
Quick ratio
0.749
Long term debt to equity
0.228
Total debt to equity
0.328
Dividend payout ratio (TTM)
46.98%
Profitability
EBITDA (TTM)
1,039.918
Gross margin (TTM)
38.13%
Net profit margin (TTM)
10.59%
Operating margin (TTM)
17.66%
Effective tax rate (TTM)
21.16%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
8.20%
Return on equity (TTM)
14.73%
Valuation
Price to earnings (TTM)
9.571
Price to revenue (TTM)
1.01
Price to book
1.41
Price to tangible book (TTM)
91.61
Price to free cash flow (TTM)
8.441
Free cash flow yield (TTM)
11.85%
Free cash flow per share (TTM)
5.306
Dividend yield (TTM)
4.99%
Forward dividend yield
5.08%
Growth
Revenue change (TTM)
3.61%
Earnings per share change (TTM)
-7.40%
3-year revenue growth (CAGR)
-1.32%
10-year revenue growth (CAGR)
2.36%
3-year earnings per share growth (CAGR)
1.41%
10-year earnings per share growth (CAGR)
5.62%
3-year dividend per share growth (CAGR)
9.53%
10-year dividend per share growth (CAGR)
11.46%
What the Analysts think about Amdocs
Analyst ratings (Buy, Hold, Sell) for Amdocs stock.
Analyst projections of the future price of Amdocs stock.
Bulls say / Bears say
Amdocs is turning its agentic AI pitch into sizeable customer programmes: it announced an eight-year agreement with AT&T, its largest customer, alongside three further strategic aOS deals. These wins could deepen long-term relationships and create room to sell more services. (Amdocs)
The EIS acquisition gives Amdocs an entry into insurance, broadening its addressable market beyond telecoms. Management sees insurance as a potential longer-term growth engine, although delivery will depend on integrating and scaling the platform. (Amdocs)
Before the new-year downturn, Amdocs generated $4.7 billion in fiscal 2026 revenue and grew non-GAAP earnings per share by 6%; it also repurchased $511 million of shares. That cash-generating record and planned dividend increase provide some support while the business resets. (Amdocs)
The dispute with T-Mobile, a major customer, creates a risk of contract termination or arbitration after both sides alleged breaches. Amdocs forecasts fiscal 2027 pro forma revenue down 7%–11% and non-GAAP earnings per share down 26%–30%. (Amdocs)
Amdocs’ adjusted 12-month backlog was down 9.6% year on year and about $370 million sequentially. That points to weaker near-term contracted revenue visibility, beyond the uncertainty around any single customer dispute. (Amdocs)
Amdocs faces a risk that telecom operators use agentic AI to build or upgrade billing and network-support systems themselves, reducing demand for external providers. Oppenheimer cited this possibility when downgrading the shares to Perform. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.
Amdocs Financial Performance
Revenues and expenses
Amdocs Earnings Performance
Company profitability
Upcoming events
Amdocs News
AllArticlesVideos

ROSEN, A LEADING LAW FIRM, Encourages Amdocs Limited Investors to Inquire About Securities Class Action Investigation - DOX
Newsfile Corp5 days ago

DOX INVESTORS: Securities Fraud Investigation by Block & Leviton Could Allow Amdocs Investors to Recover Losses
Newsfile Corp6 days ago

DOX Investors Have Opportunity to Join Amdocs Limited Fraud Investigation with SBS Law
Business Wire1 week ago
Funds containing Amdocs
Fund name | Fund size | $DOX weighting |
|---|---|---|
Invesco Dow Jones Islamic Global Developed Markets$IGDA | $1.1B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.